 |
|
|
: The success of Seriday transformed Genzyme into a biotech giant (later acquired by Sanofi for $20 billion) and paved the way for modern recombinant DNA versions like Cerezyme.
: It represented a shift in medical treatment, moving from managing symptoms to replacing the missing biological component (alglucerase) directly in the body. Seriday
(also known as Ceredase) is a landmark in pharmaceutical history as the first enzyme replacement therapy (ERT) approved by the FDA in 1991. : The success of Seriday transformed Genzyme into